Questions
Semaglutide, answered.
Common questions about semaglutide, answered directly from the cited research — no advice, no sales.
How does semaglutide work?
Semaglutide copies GLP-1, a gut hormone that signals fullness, and activates its receptor for about a week instead of minutes. Most of its weight effect is central: in rodents it reached the brainstem and hypothalamic appetite circuits, reduced food intake and altered food preference without lowering energy expenditure [4]. In the body it also boosts glucose-dependent insulin release and slows the stomach [5].
How long does it take for semaglutide to suppress appetite?
The research describes appetite suppression as central and dose-related rather than giving a fixed countdown. In rodents, semaglutide reduced food intake by acting on brainstem and hypothalamic appetite circuits [4], and the human dosing schedules deliberately step the dose up over weeks to manage tolerability [16]. Individual timing varies and is not something this digest can specify.
Why does semaglutide make you tired?
Tiredness, especially early on, is frequently reported by the patient community but is anecdotal, not a confirmed clinical mechanism. In trials, the dominant adverse effects are gastrointestinal, and a dedicated safety review describes the overall profile as favorable with mostly mild-to-moderate transient effects [5]. Reported fatigue is often linked by users to eating and drinking too little during the early weeks.
How does semaglutide reduce appetite in the brain?
It reaches appetite-control regions directly — the brainstem area postrema and the hypothalamic arcuate and parabrachial nuclei — through areas with a leaky blood-brain barrier [4]. Inside the arcuate nucleus it tips the balance toward satiety (POMC/CART) neurons and away from hunger (NPY/AgRP) neurons [8], a region shown to be required for GLP-1 receptor agonist weight loss [9].
What is semaglutide?
Semaglutide is a 31-amino-acid peptide and a GLP-1 receptor agonist — an analogue of the gut hormone GLP-1, engineered to resist breakdown and last about a week [5]. It is an FDA-approved medicine for type 2 diabetes, chronic weight management, cardiovascular risk reduction in established heart disease, and (in 2025) the fatty-liver condition MASH [1][3].
What is semaglutide used for?
It is approved for type 2 diabetes, chronic weight management, and reducing cardiovascular events in adults with established cardiovascular disease and overweight or obesity, with a 2025 indication for MASH. The weight evidence comes from STEP 1 (-14.9% mean weight change) [1] and the cardiovascular evidence from SELECT (20% fewer major events) [3]; FLOW added a kidney benefit in diabetes [6].
How does semaglutide work for weight loss?
It lowers weight mainly by reducing appetite through central pathways, not by raising metabolism. In rodents it cut food intake via brainstem and hypothalamic circuits without changing energy expenditure [4]. In humans, once-weekly 2.4 mg produced a mean body-weight change of -14.9% over 68 weeks in STEP 1, versus -2.4% on placebo [1].
What is the semaglutide dosage for weight loss?
In STEP 1, the subcutaneous schedule stepped up over four-week intervals — 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg — to a 2.4 mg once-weekly maintenance dose, which produced the -14.9% mean weight change [1]. This is the trial schedule reported as documented; it is not a recommendation, and dosing decisions belong to a prescriber.
How many mg is 40 units of semaglutide?
This digest does not convert "units" to milligrams, because that arithmetic depends on a specific product's concentration and is exactly the kind of self-dosing calculation that can go wrong. Regulators documented dosing errors with compounded semaglutide measured this way [2]. Approved semaglutide is dosed in milligrams on a stepped schedule [1]; conversions are a matter for a prescriber and the specific labeling.
What is compounded semaglutide?
Compounded semaglutide is prepared by a compounding pharmacy rather than as the approved manufactured product. It was permitted during a declared shortage from roughly 2022 to early 2025, then curtailed once the shortage was resolved [2]. It sits outside the approved-product evidence base, and regulators documented dosing errors, hospitalizations and products with unverified ingredients.
What are the side effects of semaglutide?
The dominant side effects are gastrointestinal — nausea, vomiting, diarrhea and constipation — mostly mild-to-moderate and transient, and the leading reason people stop [5][16]. Other documented concerns include gallstones, a boxed warning for thyroid C-cell tumors (unconfirmed in humans), an acute-pancreatitis class warning, and more retinopathy complications with rapid glucose correction in diabetes [2][5][17]. See the effects page.
How long does it take for semaglutide to work?
Blood-sugar and appetite effects begin while the dose is still being increased, but the doses are titrated over weeks and the pivotal weight outcome was measured at 68 weeks in STEP 1 [1]. The drug's roughly one-week half-life means levels build to steady state over several weeks [23]. The research reports endpoints at fixed timepoints rather than promising an individual onset.
How long does semaglutide stay in your system?
Semaglutide has an elimination half-life of about one week (roughly 165-168 hours), with effectively complete clearance around five weeks after the last dose [23]. That slow clearance comes from tight albumin binding plus DPP-4 resistance [5], and it is why pregnancy guidance advises stopping roughly two months before a planned conception [23].
What is the half-life of semaglutide?
About one week — commonly cited as 165-168 hours — for both the injection and the oral tablet [23]. This long half-life is conferred by the C18 fatty-acid side chain that binds albumin reversibly and the position-8 substitution that blocks DPP-4 degradation [5]. It is the structural basis for once-weekly dosing.
Is oral semaglutide as effective as the injection?
A meta-analysis of once-daily oral semaglutide reported efficacy in glycemic control and weight with a cardiovascular profile consistent with the GLP-1 receptor agonist class in type 2 diabetes [11], and higher oral doses (25 mg, 50 mg) improved outcomes further in PIONEER PLUS [13]. Oral bioavailability is low (~0.4-1%), so the tablet must be taken fasted for it to work [24].
Why am I not losing weight on semaglutide?
This digest can't diagnose an individual, and that question belongs to a prescriber. Trial averages set context: STEP 1 reported a mean -14.9% change, but a mean is an average around which individuals vary [1]. The dose is also titrated gradually over weeks [16], so the full studied dose is not reached immediately. Response differs from person to person.
Does semaglutide make you tired?
Fatigue is commonly reported by the patient community, but it is anecdotal rather than an established trial finding; the documented adverse-effect profile is dominated by transient gastrointestinal effects [5]. Community reports often link early tiredness to eating and drinking too little while appetite is suppressed — context, not a confirmed causal mechanism.
Is semaglutide a GLP-1?
Yes — semaglutide is a GLP-1 receptor agonist, a long-acting analogue of the gut hormone glucagon-like peptide-1 [5]. It activates the GLP-1 receptor to mimic that hormone's effects on insulin secretion, appetite and gastric emptying, but is engineered to last about a week rather than minutes.
Does semaglutide cause hair loss?
A pharmacovigilance analysis flagged a reporting signal for hair loss with semaglutide and tirzepatide [21], and a separate study linked diffuse shedding (telogen effluvium) to the magnitude and rate of weight loss [22]. The signal is most consistent with rapid-weight-loss-associated shedding, which is usually reversible, rather than a direct drug effect.
How fast does semaglutide work?
Effects build gradually because the dose is titrated upward over weeks and the drug reaches steady state over roughly five half-lives — about five weeks given its one-week half-life [23]. The pivotal weight result in STEP 1 was measured at 68 weeks [1]. The research reports outcomes at set timepoints rather than guaranteeing a rapid individual response.
What is the difference between semaglutide and tirzepatide?
Tirzepatide engages two receptors (GIP and GLP-1); semaglutide engages one (GLP-1). In the head-to-head SURMOUNT-5 trial in adults with obesity, tirzepatide produced greater mean weight loss at 72 weeks — -20.2% versus -13.7% for semaglutide [7]. Semaglutide carries the larger cardiovascular and kidney outcome record (SELECT, FLOW) [3][6].
What is the downside of semaglutide?
The main downsides are a real gastrointestinal side-effect burden (nausea, vomiting, diarrhea, constipation) [5][16], substantial weight regain after stopping — about 11.6 percentage points within a year in the STEP 1 extension [19] — and loss of some muscle mass alongside fat [18]. There are also specific contraindications and warnings detailed on the effects page.